303 related articles for article (PubMed ID: 31640102)
1. Transplantation of Mesenchymal Stem Cells Improves Amyloid-β Pathology by Modifying Microglial Function and Suppressing Oxidative Stress.
Yokokawa K; Iwahara N; Hisahara S; Emoto MC; Saito T; Suzuki H; Manabe T; Matsumura A; Matsushita T; Suzuki S; Kawamata J; Sato-Akaba H; Fujii HG; Shimohama S
J Alzheimers Dis; 2019; 72(3):867-884. PubMed ID: 31640102
[TBL] [Abstract][Full Text] [Related]
2. Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
Kawanishi S; Takata K; Itezono S; Nagayama H; Konoya S; Chisaki Y; Toda Y; Nakata S; Yano Y; Kitamura Y; Ashihara E
J Alzheimers Dis; 2018; 64(2):563-585. PubMed ID: 29914020
[TBL] [Abstract][Full Text] [Related]
3. Early administration of galantamine from preplaque phase suppresses oxidative stress and improves cognitive behavior in APPswe/PS1dE9 mouse model of Alzheimer's disease.
Saito T; Hisahara S; Iwahara N; Emoto MC; Yokokawa K; Suzuki H; Manabe T; Matsumura A; Suzuki S; Matsushita T; Kawamata J; Sato-Akaba H; Fujii HG; Shimohama S
Free Radic Biol Med; 2019 Dec; 145():20-32. PubMed ID: 31536772
[TBL] [Abstract][Full Text] [Related]
4. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
[TBL] [Abstract][Full Text] [Related]
5. Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP/PS1 Alzheimer mice.
Naaldijk Y; Jäger C; Fabian C; Leovsky C; Blüher A; Rudolph L; Hinze A; Stolzing A
Neuropathol Appl Neurobiol; 2017 Jun; 43(4):299-314. PubMed ID: 26918424
[TBL] [Abstract][Full Text] [Related]
6. Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in Alzheimer's disease mice.
Ma T; Gong K; Ao Q; Yan Y; Song B; Huang H; Zhang X; Gong Y
Cell Transplant; 2013; 22 Suppl 1():S113-26. PubMed ID: 24070198
[TBL] [Abstract][Full Text] [Related]
7. CD14 and Toll-Like Receptor 4 Promote Fibrillar Aβ42 Uptake by Microglia Through A Clathrin-Mediated Pathway.
Fujikura M; Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Manabe T; Matsushita T; Suzuki S; Shimohama S
J Alzheimers Dis; 2019; 68(1):323-337. PubMed ID: 30775984
[TBL] [Abstract][Full Text] [Related]
8. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses.
Lee JK; Schuchman EH; Jin HK; Bae JS
Stem Cells; 2012 Jul; 30(7):1544-55. PubMed ID: 22570192
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model.
Lee JK; Jin HK; Bae JS
Neurosci Lett; 2009 Jan; 450(2):136-41. PubMed ID: 19084047
[TBL] [Abstract][Full Text] [Related]
10. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
11. Amniotic Mesenchymal Stem Cells Decrease Aβ Deposition and Improve Memory in APP/PS1 Transgenic Mice.
Zheng XY; Wan QQ; Zheng CY; Zhou HL; Dong XY; Deng QS; Yao H; Fu Q; Gao M; Yan ZJ; Wang SS; You Y; Lv J; Wang XY; Chen KE; Zhang MY; Xu RX
Neurochem Res; 2017 Aug; 42(8):2191-2207. PubMed ID: 28397068
[TBL] [Abstract][Full Text] [Related]
12. Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression.
Go M; Kou J; Lim JE; Yang J; Fukuchi KI
Biochem Biophys Res Commun; 2016 Oct; 479(2):331-337. PubMed ID: 27641666
[TBL] [Abstract][Full Text] [Related]
13. Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Fujikura M; Manabe T; Suzuki H; Matsushita T; Suzuki S; Shimohama S
J Alzheimers Dis; 2017; 55(3):1235-1247. PubMed ID: 27814300
[TBL] [Abstract][Full Text] [Related]
14. Gossypetin ameliorates 5xFAD spatial learning and memory through enhanced phagocytosis against Aβ.
Jo KW; Lee D; Cha DG; Oh E; Choi YH; Kim S; Park ES; Kim JK; Kim KT
Alzheimers Res Ther; 2022 Oct; 14(1):158. PubMed ID: 36271414
[TBL] [Abstract][Full Text] [Related]
15. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.
Hickman SE; Allison EK; El Khoury J
J Neurosci; 2008 Aug; 28(33):8354-60. PubMed ID: 18701698
[TBL] [Abstract][Full Text] [Related]
16. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
17. Peripheral Blood-Derived Microglia-Like Cells Decrease Amyloid-β Burden and Ameliorate Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
Kuroda E; Takata K; Nishimura K; Oka H; Sueyoshi M; Aitani M; Kouda A; Satake S; Shima C; Toda Y; Nakata S; Kitamura Y; Ashihara E
J Alzheimers Dis; 2020; 73(1):413-429. PubMed ID: 31796681
[TBL] [Abstract][Full Text] [Related]
18. Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer's disease.
Kim DH; Lee D; Lim H; Choi SJ; Oh W; Yang YS; Chang JH; Jeon HB
Biochem Biophys Res Commun; 2018 Oct; 504(4):933-940. PubMed ID: 30224067
[TBL] [Abstract][Full Text] [Related]
19. Microglial autophagy is impaired by prolonged exposure to β-amyloid peptides: evidence from experimental models and Alzheimer's disease patients.
Pomilio C; Gorojod RM; Riudavets M; Vinuesa A; Presa J; Gregosa A; Bentivegna M; Alaimo A; Alcon SP; Sevlever G; Kotler ML; Beauquis J; Saravia F
Geroscience; 2020 Apr; 42(2):613-632. PubMed ID: 31975051
[TBL] [Abstract][Full Text] [Related]
20. Microglial amyloid beta clearance is driven by PIEZO1 channels.
Jäntti H; Sitnikova V; Ishchenko Y; Shakirzyanova A; Giudice L; Ugidos IF; Gómez-Budia M; Korvenlaita N; Ohtonen S; Belaya I; Fazaludeen F; Mikhailov N; Gotkiewicz M; Ketola K; Lehtonen Š; Koistinaho J; Kanninen KM; Hernández D; Pébay A; Giugno R; Korhonen P; Giniatullin R; Malm T
J Neuroinflammation; 2022 Jun; 19(1):147. PubMed ID: 35706029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
